+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Human papillomavirus L1 capsid protein and human papillomavirus type 16 as prognostic markers in cervical intraepithelial neoplasia 1



Human papillomavirus L1 capsid protein and human papillomavirus type 16 as prognostic markers in cervical intraepithelial neoplasia 1



International Journal of Gynecological Cancer 20(2): 288-293



The aim of the study was to determine whether human papillomavirus (HPV) L1 capsid protein and the HPV genotype can predict the disease course as prognostic markers for cervical intraepithelial neoplasia 1 (CIN1). Immunohistochemical staining was performed for HPV L1 capsid protein in 101 women who had been confirmed to have CIN1 by histologic examination and HPV high-risk infection by HPV genotyping. The disease course was analyzed by follow-up histologic examination according to the HPV L1 capsid protein and HPV genotype over a minimum of 12 months. The CIN1 regressed spontaneously in 60.4% of the women; most cases of regression occurred within 1 year (90.9% of regression cases). The HPV L1 capsid protein-positive patients had a spontaneous regression rate of 72.7% (48/66) and a rate of persistent disease or progression to higher grade disease of 27.3% (18/66). The HPV L1 capsid protein-negative women had a regression rate of 37.1% (13/35) and a rate of persistent disease or progression of 62.9% (22/35; P < 0.001). The HPV-16-infected patients had a regression rate of 38.6% (17/44) and a rate of persistent disease or progression of 61.4% (27/44), whereas the non-HPV-16-infected patients had a regression rate of 77.2% (44/57) and a rate of persistent disease or progression of 22.8% (13/57; P < 0.001). The HPV L1 protein expression is closely related to spontaneous disease regression, but HPV-16 infection is related to persistent disease or progression to high-grade lesions in patients with CIN1.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053611600

Download citation: RISBibTeXText

PMID: 20134272

DOI: 10.1111/igc.0b013e3181cd184c


Related references

Association of human papillomavirus L1 capsid protein with koilocytosis, expression of p16, and Ki-67, and its potential as a prognostic marker for cervical intraepithelial neoplasia. Analytical and Quantitative Cytopathology and Histopathology 35(3): 139-145, 2014

Serial measurement of type-specific human papillomavirus load enables classification of cervical intraepithelial neoplasia lesions according to occurring human papillomavirus-induced pathway. European Journal of Cancer Prevention 26(2): 156-164, 2016

Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens. American Journal Of Obstetrics & Gynecology. 174(3): 937-942, 1996

Comparison of cervical and blood T-cell responses to human papillomavirus-16 in women with human papillomavirus-associated cervical intraepithelial neoplasia. Immunology 119(4): 507-514, 2006

Detection of E5 protein in human papillomavirus type 16 positive cervical intraepithelial neoplasia exfoliated cells. Journal of Cellular Biochemistry Suppl. 0(18C): 223, 1994

Combined human papillomavirus DNA and human papillomavirus-like particle serologic assay to identify women at risk for high-grade cervical intraepithelial neoplasia. International Journal of Cancer 120(1): 55-59, 2006

Prognostic value of human papillomavirus types 16 and 18 DNA physical status in cervical intraepithelial neoplasia. Clinical Microbiology and Infection 19(10): E447-E450, 2014

Prognostic value of DNA and mRNA e6/e7 of human papillomavirus in the evolution of cervical intraepithelial neoplasia grade 2. Biomarker Insights 9: 15-22, 2014

Human papillomavirus DNA and genotypes: prognostic factors for progression of cervical intraepithelial neoplasia. International Journal of Gynecological Cancer 4(2): 73-78, 1994

Human papillomavirus detection in cervical lesions nondiagnostic for cervical intraepithelial neoplasia: correlation with Papanicolaou smear, colposcopy, and occurrence of cervical intraepithelial neoplasia. Obstetrics and Gynecology 75(6): 1006-1011, 1990

Phase I/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein-based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia. Cancer Immunology, ImmunoTherapy 53(7): 642-650, 2004

Expression of the C-terminal of the E2 protein of human papillomavirus type 16 is conserved in high grade cervical intraepithelial neoplasia and invasive squamous carcinoma. Journal of Pathology 179(SUPPL ): 12A, 1996

Expressions of programmed death (PD)-1 and PD-1 ligand (PD-L1) in cervical intraepithelial neoplasia and cervical squamous cell carcinomas are of prognostic value and associated with human papillomavirus status. Journal of Obstetrics and Gynaecology Research 43(10): 1602-1612, 2017

Human papillomavirus viral load in cervical intraepithelial neoplasia as a prognostic factor in a Mexican population. Genetics and Molecular Research 11(4): 4720-4727, 2013

High-risk human papillomavirus E6/E7 mRNA and L1 DNA as markers of residual/recurrent cervical intraepithelial neoplasia. Oncology Reports 28(1): 346-352, 2012